2007
DOI: 10.1111/j.1365-4632.2007.03190.x
|View full text |Cite
|
Sign up to set email alerts
|

Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis

Abstract: A patient with erythroderma and concomitant diagnosis of "idiopathic" HES may warrant further investigation for CTCL.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 57 publications
0
6
0
Order By: Relevance
“…As reported in the literature, CTCLs are associated with peripheral blood eosinophilia in 14% of patients with plaque phase disease. 6 This is a result of the action of eosinophilopoietic cytokines secreted by neoplastic cells, including interleukins (IL) 4, 5 and 10. 7 On the other hand, in patients with HIV infection eosinophilia is found in up to 28% of the cases, 8,9 with higher rates in those with advanced disease.…”
Section: Discussionmentioning
confidence: 99%
“…As reported in the literature, CTCLs are associated with peripheral blood eosinophilia in 14% of patients with plaque phase disease. 6 This is a result of the action of eosinophilopoietic cytokines secreted by neoplastic cells, including interleukins (IL) 4, 5 and 10. 7 On the other hand, in patients with HIV infection eosinophilia is found in up to 28% of the cases, 8,9 with higher rates in those with advanced disease.…”
Section: Discussionmentioning
confidence: 99%
“…Their ability to covalently modify nucleic acids is used in process called "extracorporeal photopheresis" that is medically necessary for either of the following clinical indications: erythrodermic variants of cutaneous T-cell lymphoma (e.g. mycosis fungioides, Sezary's syndrome) or chronic graft-versus-host disease, refractory to standard immunosuppressive therapy (Hotlick et al, 2008;Lee et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Recent reports have highlighted the protean clinical presentations of HES, including watershed cerebral infarction (McMillan et al , 2008), with sarcoma and granulocyte macrophage‐colony stimulating factor (GM‐CSF) production (Ando et al , 2007), orbital pseudotumour (Zenone & Ligeon‐Ligeonnet, 2005), retro‐orbital mass (Vigna et al , 2008), Budd Chiari syndrome (Becker et al , 2006; Inoue et al , 2007), erythroderma (Granjo et al , 2002; Lee et al , 2007), thrombosis of the cerebral superior sagital sinus (Sakuta et al , 2007), Kimura disease (Barge et al , 2008), Buerger disease (Kawata et al , 2007), lymphoma (Bae et al , 2007; Capovilla et al , 2008), with haemolytic anaemia and eosinophil erythrophagocytosis (Kuk et al , 2006), during pregnancy (Ogasa et al , 2006; Ault et al , 2009), with pemphigoid nodularis (von Felbert et al , 2006), with recurrent optic neuritis (Lincoff & Schlesinger, 2005), brachial artery occlusion (Ponsky et al , 2005), and, especially, with superficial venous thrombosis (Liao et al , 2005; Terrier et al , 2006; Sakuta et al , 2007). Mucosal ulcers of the mouth, genitalia and anus should alert the clinician to a particular variant, myeloproliferative HES (Leiferman et al , 1982; Leiferman & Gleich, 2004).…”
Section: Clinical Presentations Of Hesmentioning
confidence: 99%